Abstract
Targeted delivery systems aim to deliver drugs to their intended site of action and as such they are expected to show more desired effects and less unwanted effects. The system itself is composed of a vesicle-encapsulated drug with “target recognition molecules” on the envelop. Ideally, these target recognition molecules, being either small non-peptidic molecules or peptides, are basically high-affinity ligands for a receptor or other protein that is expressed specifically and at high concentrations on the target cells. This review will focus on several widely used examples of target recognition molecules and on how molecular modelling studies have been used in the development of nano drug carrier systems in general.
Keywords: Targeted drug delivery, Nano drug delivery systems, Docking, Molecular dynamics, Central nervous system, Cell penetrating peptides.
Graphical Abstract
Current Topics in Medicinal Chemistry
Title:Target Recognition Molecules and Molecular Modeling Studies
Volume: 17 Issue: 13
Author(s): Burcu Culhaoglu and Atilla Akdemir*
Affiliation:
- Department of Pharmacology, Faculty of Pharmacy, Bezmialem Vakif University, 34093, Istanbul,Turkey
Keywords: Targeted drug delivery, Nano drug delivery systems, Docking, Molecular dynamics, Central nervous system, Cell penetrating peptides.
Abstract: Targeted delivery systems aim to deliver drugs to their intended site of action and as such they are expected to show more desired effects and less unwanted effects. The system itself is composed of a vesicle-encapsulated drug with “target recognition molecules” on the envelop. Ideally, these target recognition molecules, being either small non-peptidic molecules or peptides, are basically high-affinity ligands for a receptor or other protein that is expressed specifically and at high concentrations on the target cells. This review will focus on several widely used examples of target recognition molecules and on how molecular modelling studies have been used in the development of nano drug carrier systems in general.
Export Options
About this article
Cite this article as:
Culhaoglu Burcu and Akdemir Atilla*, Target Recognition Molecules and Molecular Modeling Studies, Current Topics in Medicinal Chemistry 2017; 17 (13) . https://dx.doi.org/10.2174/1568026616666161222100702
DOI https://dx.doi.org/10.2174/1568026616666161222100702 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Increasing Testosterone Levels and Effects on Cognitive Functions in Elderly Men and Women: A Review
Current Drug Targets - CNS & Neurological Disorders Anti-Cancer Cytotoxic Effects of Multiwalled Carbon Nanotubes
Current Pharmaceutical Design Monoclonal Antobodies: Application in Radiopharmacy
Current Radiopharmaceuticals The Pathogenic Subpopulation of Th17 Cells in Obesity
Current Pharmaceutical Design Monoclonal Antibodies Against Epidermal Growth Factor Receptor in Advanced Colorectal Carcinoma: Clinical Efficacy and Markers of Sensitivity&#
Reviews on Recent Clinical Trials Psychosocial Factors and Central Sensitivity Syndromes
Current Rheumatology Reviews New Insights in Mast Cell Modulation by Palmitoylethanolamide
CNS & Neurological Disorders - Drug Targets Age-Related Decline in Melatonin and Its MT1 Receptor Are Associated with Decreased Sensitivity to Melatonin and Enhanced Mammary Tumor Growth
Current Aging Science Clinical Impact of Gene Expression Profiling on Oncology Diagnosis, Prognosis, and Treatment
Combinatorial Chemistry & High Throughput Screening New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics
Current Topics in Medicinal Chemistry PARP Inhibitors in Ovarian Cancer
Recent Patents on Anti-Cancer Drug Discovery MicroRNAs as Biomarkers for Birth Defects
MicroRNA Base-Modified Nucleosides as Chemotherapeutic Agents: Past and Future
Current Topics in Medicinal Chemistry Cadherins: The Superfamily Critically Involved in Breast Cancer
Current Pharmaceutical Design Advances and Recent Self-Assembled Patented Structures for Breast Cancer Therapy
Recent Patents on Materials Science Antibody-directed Double Suicide Gene Therapy Targeting of MUC1- Positive Leukemia Cells In Vitro and In Vivo
Current Gene Therapy Metabolic Effects of Bile Acids in the Gut in Health and Disease
Current Medicinal Chemistry Patent Selections
Recent Patents on DNA & Gene Sequences Recent Indications and Methods of Surgery for Inflammatory Bowel Disease
Current Drug Targets - Inflammation & Allergy Development and Assessment of Conventional and Targeted Drug Combinations for Use in the Treatment of Aggressive Breast Cancers
Current Cancer Drug Targets